Award notice Supplies
Produkty farmaceutyczne
Notice published in Polish. The AI analysis summarises it for you in your language.
- Public buyer
- Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy
Otwock - Place of performance
- Otwock
- Planned end of contract
- 7 May 2027
likely re-tender around November 2026 - Bids received
- 5
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 11 September 2026
- Notice language
- Polish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Środki przeciwnowotworowe
Awarded to
25 lots
- Cyclophosphemid
- Ondosetron
- Ondosetron
- Atezolizumab
- Paclitaxel
- Vinorelbina
- Doxorubicyna
- Brigatinib
- Afatinib
- Alektynib
- Erlotynib
- Sotorasib
- Krizotynib
- Pembrolizumab
- Pemetrexed
- Topotecan
- Etoposide
- Nintedanib
- Nivolumab
- Vinorelbina
- Carboplatyna
- Docetaxel
- Gemcitabine
- Cisplatinum
- Lorlatynib
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 627252-2026.